Therefore, molecular pathways characterizing intestinal-type tumors, together with other cancer-related pathways, are involved in cell cycle regulation and the response to growth factors and hormones (EGFR, estradiol, and progesterone) [11,39]. This evidence concerns the gene EGFR and cancer.